TY - JOUR AU - Kunal Kishor AU - Dinesh Sinha AU - Manish Kumar AU - Shashi Pawar AU - Richa Madhawi AU - Shraddha Raj AU - Rajesh Singh AU - Seema Devi AU - Rajiv Prasad PY - 2020/08/29 Y2 - 2024/03/28 TI - Brain Tumor Management Amidst COVID-19 Pandemic JF - Asian Pacific Journal of Cancer Care JA - apjcc VL - 5 IS - S1 SE - Perspectives and View Points DO - 10.31557/apjcc.2020.5.S1.235-238 UR - http://www.waocp.com/journal/index.php/apjcc/article/view/525 AB - In May, Brain Tumor Awareness Month, we are facing challenges pertaining to brain cancer and coronavirus (COVID-19) pandemic. With no effective treatment and no vaccine currently available, the most effective means of slowing the dissemination of COVID-19 is through social distancing, crowd avoidance, appropriate quarantine, and other techniques intended to limit community exposure. However, in this ongoing pandemic era, timely treatment by surgery is critical to reduce the tumor mass inside a patient’s brain. By giving drug therapy to slow down the tumor’s progression and provide a longer survival time is utmost important. As hospitals across the country postpone elective procedures to increase the capacity for COVID-19 patients, there is a lot of uncertainty among the neuro-oncology community. Patient having multiple co-morbidities poses challenges for centers that may need access to ventilator care due to insufficient critical care facilities across the country. This crisis is straining our health care sy tem, as this viral infection continues to escalate. It is the time for the neuro-oncology team to develop a uniform and acceptable approach to the brain tumor patient. We present an approach developed by an international multidisciplinary group to provide them best possible care during this pandemic as well as reducing their chance of viral infection. ER -